You have successfully logged out.

Hello !
Logout

Reducing Underdosing

Underdosage 

a cause of medication errors

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professionals before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.
A drip of medication connected to a patient’s arm

In small volume infusions up to 32.2% of active agent remain in IV line3

One lilac cross among nine green checkmarks

Products that can help preventing medication errors

Intrafix® SafeSet

Gravity sets (G) are IV administration sets for gravity infusion.Pressure set (P) are IV administration sets for gravity and pressure infusions with compatible (non-dedicated) infusion pumps (pressure resistant up to 2 bar acc. to ISO 8536-8)

Cyto-Set® Infusomat® Space

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow. Cyto-Set® Infusomat® SpaceIV administration set for the application of cytostatics. For infusion by compatible pumps.Connection set for the administration of cytostatic drugs by compatible pumps. Cyto-Set® Infusomat® Space is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusomat® Space to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Cyto-Set® Infusion 

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs / solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® InfusionIV administration set. Only for gravity infusion.Connection set for the administration of cytostatic drugs by gravity. Cyto-Set® Infusion is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusion to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Cyto-Set® Mix, Cyto-Set® Line

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system.The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® MixConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.The Cyto-Set® Mix allows to connect a normal infusion container with a solution dedicated for cytotoxic drugs (NaCl 0,9% or Glucose 5%) to vent the line. The drug is put in the container via a needle-free injection valve. So the line of the Cyto-Set® Mix leading to Cyto-Set® Infusion, Cyto-Set® Infusomat® Space or Cyto-Set® Infusomat® plus is free of cytotoxic drugs.Cyto-Set® LineConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.Cyto-Set® Line connects primed solutions. This component consists of only one spike and a polyurethane transition tube, clamp and a fill-stop-cap (Prime Stop).Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

References

1. Toh MR et al, Prev Med Reports 2014;1:43-473. Plagge H et al, EJHPScience 2010;16:31-37

2. Hughes RG et al, Evidence-based Handbook for Nurses 2008; US Dept of Health and Human Services

3. Plagge H et al, EJHPSCience 2010;16:31-37

4. https://www.england.nhs.uk/signuptosafety/wp-content/uploads/sites/16/2015/11/su2s-infusing-iv-antibiotics-webinar.pdf

5. Cousins D et al, Clinical Pharmacist 2018;10(12):356-357

6. Patient Safety Observer, 2007

7. Cooper DM et al, Bri J Nurs 2018;27:2-6

8. Gregerson BG et al, Proc Bayl Univ Med Cent 2018;31(2):168-170

9. Chan YK et al, CMBES Proc., vol 36, no1, May 2013

10. Letter by Cousins D in the Clinical Pharmacist & Cooper et al

11. https://www.ismp.org/resources/hidden-medication-loss-when-using-primary-administration-set-small-volume-intermittent

12. MacLachlan L et al, Antimicrobial Stewardship – Ensuring full prescribed Dose Delivery of IV Antibiotics in OPAT, Hull University Teaching Hospitals, NHS Trust

13. Fish and Ohlinger, 2006

14. CDC 2015, https://www.cdc.gov/drugresistance/biggest-threats.html

15. Gurney H et al, Bri J Cancer 2002;86:1297-1302

16. Bowman S et al, Anaesthesia 2013;68:557-561

17. Cooper DM et al, BJON 2018;27:14(suppl_000

18. https://www.ismp.org/resources/additional-strategies-improve-complete-delivery-small-volume-intermittent-infusions

19. Peyko, V., An unrecognized Problem in Optimizing Antimicrobial Therapy: Significant Residual Volume Remaining in Intravenous Tubing With Extended-Infusion Piperacillin-Tazobactam, 2021 Journal of Pharmacy Practice Vol. 0.0 1-4